
NATURE . COM {
}
Title:
Characteristics of human tumour xenografts transplanted under the renal capsule of immunocompetent mice | British Journal of Cancer
Description:
Human tumour lines established in athymic nude mice were grafted under the renal capsule of immunocompetent mice. Grafts from 27 human tumour lines comprising 9 malignant melanomas, 10 sarcomas, 2 colon carcinomas, 4 lung carcinomas and 2 mammary carcinomas, grew well under the renal capsule of the immunocompetent mice and retained morphological and functional characteristics of the parent tumours, as judged by light and electron microscopy and immunohistochemical examinations. Numerous mitoses were detected. Granulation tissue and necrosis were not predominant features. After Day 4, the grafts became infiltrated from the periphery by mouse inflammatory cells. The infiltration could be prevented by pretreatment of the animals with cyclophosphamide. Anti-human antibodies were detected after Day 3. Single cell suspensions from the subrenal grafts were able to form colonies in soft agar. and upon reimplantation in nude mice, subcutaneous tumours were formed showing that the grafted tumour tissue had also retained its malignant character. Altogether the results support the view that human tumour xenografts grow well under the renal capsule of immunocompetent mice and that the grafts retain important characteristics of the original tumour.
Website Age:
30 years and 10 months (reg. 1994-08-11).
Matching Content Categories {π}
- Telecommunications
- Non-Profit & Charity
- Social Networks
Content Management System {π}
What CMS is nature.com built with?
Custom-built
No common CMS systems were detected on Nature.com, and no known web development framework was identified.
Traffic Estimate {π}
What is the average monthly size of nature.com audience?
π Monumental Traffic: 20M - 50M visitors per month
Based on our best estimate, this website will receive around 41,362,249 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Nature.com Make Money? {πΈ}
Display Ads {π―}
The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.
Ads are managed by yourbow.com. Particular relationships are as follows:
Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.comReseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.comHow Much Does Nature.com Make? {π°}
Display Ads {π―}
$521,200 per month
Our calculations suggest that Nature.com earns between $347,485 and $955,583 monthly online from display advertisements.
Keywords {π}
nature, article, access, cancer, content, journal, tumour, mice, cookies, renal, privacy, human, capsule, immunocompetent, open, data, british, characteristics, grafts, cell, research, advertising, subscribe, original, xenografts, carcinomas, institution, buy, permissions, optional, analysis, media, personal, parties, policy, information, view, journals, log, march, transplanted, aamdal, fodstad, nesland, cite, lines, nude, grafted, malignant, lung,
Topics {βοΈ}
nature portfolio cell-surface-antigen-density-dependent manner permissions reprints cancer research privacy policy nature advertising social media single cell suspensions kras/lkb1 mutant nsclc personal data springerlink instant access data protection permissions mouse inflammatory cells anti-human antibodies privacy original tumour explore content subscription content grafted tumour tissue european economic area institutional subscriptions read chemo-immuno combination accepting optional cookies journals search log spatial transcriptomics analysis manage preferences article purchase athymic nude mice content access article cite article aamdal 4 lung carcinomas malignant character results support issue learn optional cookies article journal publish οΏ½rmann journal choices essential cookies cookies skip renal capsule institution subscribe institution buy cancer models nude mice
Schema {πΊοΈ}
WebPage:
mainEntity:
headline:Characteristics of human tumour xenografts transplanted under the renal capsule of immunocompetent mice
description:Human tumour lines established in athymic nude mice were grafted under the renal capsule of immunocompetent mice. Grafts from 27 human tumour lines comprising 9 malignant melanomas, 10 sarcomas, 2 colon carcinomas, 4 lung carcinomas and 2 mammary carcinomas, grew well under the renal capsule of the immunocompetent mice and retained morphological and functional characteristics of the parent tumours, as judged by light and electron microscopy and immunohistochemical examinations. Numerous mitoses were detected. Granulation tissue and necrosis were not predominant features. After Day 4, the grafts became infiltrated from the periphery by mouse inflammatory cells. The infiltration could be prevented by pretreatment of the animals with cyclophosphamide. Anti-human antibodies were detected after Day 3. Single cell suspensions from the subrenal grafts were able to form colonies in soft agar. and upon reimplantation in nude mice, subcutaneous tumours were formed showing that the grafted tumour tissue had also retained its malignant character. Altogether the results support the view that human tumour xenografts grow well under the renal capsule of immunocompetent mice and that the grafts retain important characteristics of the original tumour.
datePublished:
dateModified:
pageStart:347
pageEnd:356
sameAs:https://doi.org/10.1038/bjc.1985.46
keywords:
Biomedicine
general
Cancer Research
Epidemiology
Molecular Medicine
Oncology
Drug Resistance
image:
isPartOf:
name:British Journal of Cancer
issn:
1532-1827
0007-0920
volumeNumber:51
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:S Aamdal
type:Person
name:ΓΒ Fodstad
type:Person
name:J M Nesland
type:Person
name:A Pihl
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Characteristics of human tumour xenografts transplanted under the renal capsule of immunocompetent mice
description:Human tumour lines established in athymic nude mice were grafted under the renal capsule of immunocompetent mice. Grafts from 27 human tumour lines comprising 9 malignant melanomas, 10 sarcomas, 2 colon carcinomas, 4 lung carcinomas and 2 mammary carcinomas, grew well under the renal capsule of the immunocompetent mice and retained morphological and functional characteristics of the parent tumours, as judged by light and electron microscopy and immunohistochemical examinations. Numerous mitoses were detected. Granulation tissue and necrosis were not predominant features. After Day 4, the grafts became infiltrated from the periphery by mouse inflammatory cells. The infiltration could be prevented by pretreatment of the animals with cyclophosphamide. Anti-human antibodies were detected after Day 3. Single cell suspensions from the subrenal grafts were able to form colonies in soft agar. and upon reimplantation in nude mice, subcutaneous tumours were formed showing that the grafted tumour tissue had also retained its malignant character. Altogether the results support the view that human tumour xenografts grow well under the renal capsule of immunocompetent mice and that the grafts retain important characteristics of the original tumour.
datePublished:
dateModified:
pageStart:347
pageEnd:356
sameAs:https://doi.org/10.1038/bjc.1985.46
keywords:
Biomedicine
general
Cancer Research
Epidemiology
Molecular Medicine
Oncology
Drug Resistance
image:
isPartOf:
name:British Journal of Cancer
issn:
1532-1827
0007-0920
volumeNumber:51
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:S Aamdal
type:Person
name:ΓΒ Fodstad
type:Person
name:J M Nesland
type:Person
name:A Pihl
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:British Journal of Cancer
issn:
1532-1827
0007-0920
volumeNumber:51
Organization:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:S Aamdal
name:ΓΒ Fodstad
name:J M Nesland
name:A Pihl
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {π}(17)
- How much income does https://link.springer.com/article/10.1038/bjc.1985.46?utm_source=nature&utm_medium=referral&utm_campaign=buyArticle have?
- How much cash flow does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=S%20Aamdal have monthly?
- How profitable is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22S%20Aamdal%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=%C3%98%20Fodstad?
- What's the revenue for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22%C3%98%20Fodstad%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=J%20M%20Nesland?
- How much profit is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22J%20M%20Nesland%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en making per month?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=A%20Pihl's revenue stream
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22A%20Pihl%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en rake in every month?
- Income figures for https://s100.copyright.com/AppDispatchServlet?title=Characteristics%20of%20human%20tumour%20xenografts%20transplanted%20under%20the%20renal%20capsule%20of%20immunocompetent%20mice&author=S%20Aamdal%20et%20al&contentID=10.1038%2Fbjc.1985.46©right=Cancer%20Research%20Campaign&publication=0007-0920&publicationDate=1985-03-01&publisherName=SpringerNature&orderBeanReset=true
- How much profit is https://citation-needed.springer.com/v2/references/10.1038/bjc.1985.46?format=refman&flavour=citation making per month?
- How much revenue does https://doi.org/10.1038/sj.bjc.6601341 produce monthly?
- Learn about the earnings of https://doi.org/10.1007/BF01294439
- How much does https://www.protocols.io/ net monthly?
- How much does https://www.natureindex.com/ gross monthly?
- How much income does http://www.naturechina.com have?
- What's the total monthly financial gain of https://www.natureasia.com/ja-jp?
Analytics and Tracking {π}
- Google Tag Manager
Libraries {π}
- Prism.js
- Zoom.js
Emails and Hosting {βοΈ}
Mail Servers:
- mxa-002c5801.gslb.pphosted.com
- mxb-002c5801.gslb.pphosted.com
Name Servers:
- pdns1.ultradns.net
- pdns2.ultradns.net
- pdns3.ultradns.org
- pdns4.ultradns.org
- pdns5.ultradns.info
- pdns6.ultradns.co.uk